Activity Description

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE)
website. CSPE is the educational hub of the National Association of Specialty Pharmacy
(NASP). Most CSPE activities include the pathophysiology and clinical therapeutics
of various disease states in which specialty pharmacy products and services are provided.
CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy
practice.

Nutrition therapy is an important part of managing oncology patient’s adverse
effects and hopefully by managing these issues it will increase the patient’s
quality of life. The nutrition status of patients with cancer can vary at presentation
and through the continuum of cancer care. It is imperative pharmacists recognize and
understand management strategies in oncology patients with anorexia, dysphagia, mucositis,
and xerostomia. Pharmacists also need to understand the uses and precautions with
vitamins and supplements in patients receiving chemotherapy.

Learning Objectives

The target audience for this activity includes pharmacists. Upon completion
of this activity, participants will be able to:

Faculty

Steering/Review Committee

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants the existence of any significant financial interest or any other relationship
with the manufacturer of any commercial product(s) discussed in an educational presentation.
Jennifer Powers has served as a Consultant for Power-Pak CE. Michael Heikkinen, Megan
May, and Marcy Snell have no relevant commercial and/or financial relationships to
disclose.

Please note: The opinions expressed in this activity should not be construed as
those of the CME/CE provider. The information and views are those of the faculty through
clinical practice and knowledge of the professional literature. Portions of this activity
may include unlabeled indications. Use of drugs and devices outside of labeling should
be considered experimental and participants are advised to consult prescribing information
and professional literature.

CE Accreditation

Release Date: 11-21-2018
Expiration Date: 11-21-2021

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the National
Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE
Universal Activity Number 0221-9999-18-390-H01-P has been assigned to this knowledge-based,
home-study activity. This CE activity is approved for 1.0 contact hour(0.1 CEU)
in states that recognize ACPE providers. Completion of an evaluation and post-test
with a score of 70% or higher is required to receive CE credit. Proof of completion
will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

This activity is self-funded by NASP.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.